Contractile reserve: are we beginning to understand it?
Francis
Gary S
GS
Desai
Milind Y
MY
D019797:3-Iodobenzylguanidine; D058665:Adrenergic beta-1 Receptor Agonists; D000318:Adrenergic beta-Agonists; D002135:Calcium-Binding Proteins / Q000235:genetics; D002311:Cardiomyopathy, Dilated / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology*; D004280:Dobutamine; D006439:Hemodynamics; D006801:Humans; D009200:Myocardial Contraction; D055414:Myocardial Perfusion Imaging; D009206:Myocardium / Q000378:metabolism; D011237:Predictive Value of Tests; D012333:RNA, Messenger / Q000378:metabolism; D019275:Radiopharmaceuticals; D018342:Receptors, Adrenergic, beta-1 / Q000235:genetics; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases / Q000235:genetics; D012720:Severity of Illness Index; D016277:Ventricular Function, Left; D017725:Ventricular Pressure; D000099211:Phospholamban
D019797:3-Iodobenzylguanidine; D058665:Adrenergic beta-1 Receptor Agonists; D000318:Adrenergic beta-Agonists; D002135:Calcium-Binding Proteins; D004280:Dobutamine; D012333:RNA, Messenger; D019275:Radiopharmaceuticals; D018342:Receptors, Adrenergic, beta-1; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases; D000099211:Phospholamban; C506946:ATP2A2 protein, human